Epigallocatechin Gallate (EGCG) Formulations: Unlocking Potential in Nutraceutical and Pharmaceutical Sectors

Abstract

Objective: This review aims to evaluate the latest techniques used in formulating epigallocatechin gallate (EGCG), analyse the difficulties encountered in the process, and offer perspectives on potential future advancements in epigallocatechin gallate formulations for both nutraceutical and pharmaceutical applications. Methods: This work provides a thorough literature review, examines current epigallocatechin gallate formulation strategies, assesses solubility improvement approaches, examines obstacles, and summarises results regarding benefits and drawbacks. In nutraceuticals and pharmaceuticals, it identifies knowledge gaps and suggests future research avenues. Results: This comprehensive review presents a synthesis of pivotal discoveries about epigallocatechin gallate formulations, particularly emphasising notable progress in enhancing solubility and the concomitant obstacles encountered in this pursuit. This review weighs the benefits and drawbacks, shedding light on areas that need further investigation in the pharmaceutical and nutraceutical fields. Conclusion: This review synthesises current research on formulations containing epigallocatechin gallate, focusing on their various applications and the obstacles accompanying their implementation. Despite facing various challenges, the methodologies that have been investigated demonstrate potential. The comprehensive evaluation of both strengths and limitations highlights the imperative nature of continuous research. The conclusion provides opportunities for research in pharmaceuticals and nutraceuticals, outlining future directions.